Dare Bioscience Inc (NASDAQ:DARE)
| 0.4683 Delayed Data As of Sep 25 |  +0.0083 / +1.80%Today’s Change | 0.45 Today|||52-Week Range 1.40 | -43.58% Year-to-Date |
Latest DARE News | Press Releases
No recent news for Dare Bioscience Inc.
Today’s Trading
| Previous close | 0.46 |
| Today’s open | 0.47 |
| Day’s range | 0.47 - 0.48 |
| Volume | 313 |
| Average volume (3 months) | 283,762 |
| Market cap | $45.2M |
Data as of 3:37pm ET, 09/25/2023
Growth & Valuation
| Earnings growth (last year) | +42.18% |
| Earnings growth (this year) | -5.86% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 7.02 |
| Price/Book | 3.51 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ODTCDOdonate Inc | 0.00 | 0.00% |
| VIRXViracta Therapeutics... | -0.05 | -4.35% |
| MRKRMarker Therapeutics ... | -0.03 | -0.61% |
| SLSSellas Life Sciences... | +0.01 | +0.66% |
Data as of 4:00pm ET, 09/25/2023
Financials
| Next reporting date | November 16, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $10.0M |
| Annual profit (last year) | -$30.9M |
| Net profit margin | -309.48% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
